Sensitive ASX Announcement

Nucleus Network Appointed to Conduct Phase 1 Clinical Trial

Published: 23/07/20, 08:36am (AEST)1 pages
Amplia Therapeutics Limited
ATX:ASXHealthcare

Recent ATX Announcements

Price Sensitive only